Select Page

The concept of microbiome-based therapeutics has generated significant enthusiasm within the medical science community, defining a new frontier in the field of medicine.
Despite having captured the interest of several venture capital firms and big pharma players, no microbiome-based therapeutic has been officially approved by an authorized medical product regulator. However, the current development pipeline of microbiome therapeutics has several promising candidates that are likely to result in commercial success stories soon.
The USD 4 billion (by 2030) financial opportunity within the Microbiome Therapeutics (Tx) Market And Diagnostics (Dx) Markets, has been analyzed across the following segments:
Type of Therapy (Tx)
• Prescription Drug
• Prebiotics
Type of Molecule (Tx)
• Small Molecules
• Biologics
Target Indication (Tx+Dx)
• Acne Vulgaris
• Atopic Dermatitis
• Clostridium difficile Infection
• Colorectal Cancer
• Crohn’s Disease
• Diabetes
• Irritable Bowel Syndrome
• Lactose Intolerance
• Lung Cancer
• Nonalcoholic steatohepatitis (NASH)
• Obesity
• Ulcerative colitis
Therapeutic Area (Tx+Dx)
• Autoimmune Disorders
• Dental Disorders
• Digestive and Gastrointestinal Disorders
• Dermatological Disorders
• Infectious Disease
• Metabolic Disorders
• Oncology
• Others
Key Geographical Regions (Tx+Dx)
• North America
• Europe
• Asia-Pacific and Rest of the World

The Human Microbiome Market, 2019-2030 report features the following companies, which we identified to be key players in this domain:
Key Players:
• 4D Pharma
• Armata Pharmaceuticals
• Evelo Biosciences
• Rebiotix (Acquired by Ferring Pharmaceuticals)
• Seres Therapeutics
• Vedanta Biosciences
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Microbiome Therapeutics: Market Landscape
5. Company and Drug Profiles
6. Microbiome Diagnostics: Market Landscape
7. Fecal Microbiota Therapy (FMT)
8. Attractiveness Competitiveness (AC) Matrix
9. Microbiome Related Initiatives of Big Pharmaceutical Players
10. Start-up Health Indexing
11. Key Therapeutics Areas
12. Funding and Investment Analysis
13. Contract Services for Microbiome Therapeutics
14. Big Data and Microbiome Therapeutics
15. Microbiome Therapeutics: Market Forecast and Opportunity Analysis
16. Microbiome Diagnostics: Market Forecast and Opportunity Analysis
17. Fecal Microbiota Therapies: Market Forecast and Opportunity Analysis
18. Case Study: Microbiome-based Products in Other Industries
19. Concluding Remarks
20. Executive Insights
21. Appendix I: Tabulated Data
22. Appendix II: List of Companies and Organizations
For more information, please click on the following link:
https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
Gaurav.Chaudhary@rootsanalysis.com